Claris Lifesciences receives ANDA approval for Metroprolol Tartrate Injection in US

02 May 2013 Evaluate

Claris Lifesciences has received an Abbreviated New Drug Application (ANDA) approval for Metoprolol Tartrate Injection; having strength of 1mg / ml in 5 ml glass vials; in the United States of America (US). Metoprolol Tartrate Injection is used to treat angina (chest pain) and hypertension (high blood pressure). It is also used to treat or prevent heart attack.

According to the American Heart Association, an estimated 1.4 million people annually will suffer a heart attack or AMI. IMS data indicates 2009 sales of Metoprolol at approximately $13 million.

Claris is also one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 10 ANDAs approved in its name across 6 molecules. The company has a total filing of 32 ANDAs across 21 molecules.

Peers
Company Name CMP
Redington 267.95
Adani Enterprises 2208.90
Amrapali Industries 14.38
Rashi Peripheral 348.10
PDS 367.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×